WINDTREE THERAPEUTICS INC /DE/ financial data

Symbol
WINT, WINTW on OTC
Location
Warrington, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 19 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 36.5 % -20.2%
Debt-to-equity 673 % +110%
Return On Equity -1.3K % -796%
Return On Assets -156 % -389%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.3M shares +4856%
Common Stock, Shares, Outstanding 33.6M shares +1337%
Entity Public Float 1.9M USD -69.4%
Common Stock, Value, Issued 34K USD +1600%
Weighted Average Number of Shares Outstanding, Basic 26.7M shares +150270%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.54M USD -50.2%
General and Administrative Expense 1.86M USD -33.1%
Operating Income (Loss) -33.5M USD -31.1%
Nonoperating Income (Expense) -10M USD -163%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -43.5M USD -351%
Income Tax Expense (Benefit) -3.51M USD -5041%
Net Income (Loss) Attributable to Parent -40M USD -312%
Earnings Per Share, Basic 44 USD/shares +99.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 204K USD -91.1%
Assets, Current 7.21M USD +83.4%
Property, Plant and Equipment, Net 61K USD -52.3%
Operating Lease, Right-of-Use Asset 707K USD -37.6%
Goodwill 0 USD
Assets 16M USD -47.5%
Accounts Payable, Current 1.65M USD -19.6%
Employee-related Liabilities, Current 57K USD -10.9%
Accrued Liabilities, Current 2.01M USD +21.6%
Liabilities, Current 21.9M USD +51.8%
Deferred Income Tax Liabilities, Net 1.64M USD -66.4%
Operating Lease, Liability, Noncurrent 240K USD -69.4%
Other Liabilities, Noncurrent 3.8M USD 0%
Liabilities 27.6M USD +15.4%
Retained Earnings (Accumulated Deficit) -889M USD -4.78%
Stockholders' Equity Attributable to Parent -11.6M USD -363%
Liabilities and Equity 16M USD -47.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.41M USD +18.3%
Net Cash Provided by (Used in) Financing Activities 1.8M USD +74.2%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 33.6M shares +1337%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -606K USD +68.3%
Deferred Tax Assets, Valuation Allowance 52.2M USD -71.9%
Deferred Tax Assets, Gross 50.4M USD -72.8%
Operating Lease, Liability 1.16M USD -27.3%
Depreciation 17K USD -19%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.25M USD -29.8%
Property, Plant and Equipment, Gross 3.94M USD +0.31%
Operating Lease, Liability, Current 544K USD +16.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 581K USD +1.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 570K USD +7.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 87K USD -52.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 97K USD -83.3%
Deferred Tax Assets, Operating Loss Carryforwards 39.6M USD -75.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 4.97M shares -0.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 97K USD -83.3%
Additional Paid in Capital 881M USD +2.86%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 141K USD -80.9%
Interest Expense 51K USD -1.92%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%